Order Article Reprints

Tan SM, Lindblom RSJ, Ziemann M, Laskowski A, Granata C, Snelson M, Thallas-Bonke V, El-Osta A, Baeza-Garza CD, Caldwell ST, et al. Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide. Nutrients. 2021; 13(5):1457. https://doi.org/10.3390/nu13051457

Tan, Sih Min, Runa S. J. Lindblom, Mark Ziemann, Adrienne Laskowski, Cesare Granata, Matthew Snelson, Vicki Thallas-Bonke, Assam El-Osta, Carlos D. Baeza-Garza, Stuart T. Caldwell, and et al. 2021. "Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide" Nutrients 13, no. 5: 1457. https://doi.org/10.3390/nu13051457

Tan, S. M., Lindblom, R. S. J., Ziemann, M., Laskowski, A., Granata, C., Snelson, M., Thallas-Bonke, V., El-Osta, A., Baeza-Garza, C. D., Caldwell, S. T., Hartley, R. C., Krieg, T., Cooper, M. E., Murphy, M. P., & Coughlan, M. T. (2021). Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide. Nutrients, 13(5), 1457. https://doi.org/10.3390/nu13051457